 ATL, 15-epi-LXA4) and a docosahexaenoic acid metabolite, resolvin D1 (i.e.RvD1); these three cell-derived fatty acid metabolites act to inhibit and resolve inflammatory responses.This receptor was previously known as an orphan receptor, termed RFP, obtained by screening myeloid cell-derived libraries with a FMLP-like probe.